Outpatient Oncology Infusion Market Trends

Outpatient Oncology Infusion Market Trends

The rising prevalence of various types of cancer across the globe are expected to spur market growth. For instance, according to the World Cancer Report, cancer prevalence is expected to rise by approximately 50% by 2020, with over 15 million new cancer cases. Moreover, increasing tobacco and alcohol consumption has increased the global cancer burden. Thus, the above-mentioned factors are projected to expedite the outpatient oncology infusion market growth in the near future.
 

For instance, according to the National Cancer Registry of India (NCRI), in 2020, approximately 27 percent of cancer cases found in India due to tobacco consumption. As a result of the rising oncology burden, the adoption rate of oncology infusion therapy and subsequent treatment will accelerate, boosting market growth.
 

Furthermore, the estimated national cancer treatment cost in the U.S. in 2018 was USD 150.8 billion. Over the next few years, costs can increase as the population ages and more people develop cancer. Costs can also increase as new and often more expensive treatments are introduced as standard of care.